LONG-TERM SAFETY AND EFFICACY OF UPADACITINIB IN PATIENTS WITH RHEUMATOID ARTHRITIS: FINAL RESULTS FROM THE BALANCE-EXTEND OPEN-LABEL EXTENSION STUDY

被引：0
|
作者：
Kivitz, A. [1 ]
Wells, A. F. [2 ]
Vargas, J. Ignacio [3 ]
Baraf, H. S. B. [4 ,5 ]
Rischmueller, M. [6 ,7 ,8 ]
Klaff, J. [9 ]
Khan, N. [9 ]
Li, Y. [9 ]
Carter, K. [9 ]
Friedman, A. [9 ]
Durez, P. [10 ]
机构：
[1] Altoona Ctr Clin Res, Altoona Arthrit Osteoporosis Ctr, Duncansville, PA USA
[2] Aurora Rheumatol & Immunotherapy Ctr, Dept Rheumatol, Franklin, WI USA
[3] Quantum Res, Med, Las Lagos, Chile
[4] Ctr Rheumatol & Bone Res, Rheumatol, Wheaton, MD USA
[5] George Washington Univ, Rheumatol, Washington, DC USA
[6] Queen Elizabeth Hosp, Dept Rheumatol, Woodville, SA, Australia
[7] Basil Hetzel Inst, Rheumatol Res Grp, Woodville, SA, Australia
[8] Univ Adelaide, Adelaide Med Sch, Rheumatol, Adelaide, SA, Australia
[9] AbbVie Inc, Immunol, N Chicago, IL USA
[10] UCLouvain St Luc, Inst Rech Experimentale & Clin Univ St Luc, Brussels, Belgium
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2022年 / 81卷
关键词：
D O I：
10.1136/annrheumdis-2022-eular.1819
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
POS0685
引用
收藏
页码：620 / 621
页数：2
相关论文
共 50 条
  • [31] LONG-TERM SAFETY AND EFFICACY OF UPADACITINIB (ABT-494), AN ORAL JAK-1 INHIBITOR IN PATIENTS WITH RHEUMATOID ARTHRITIS IN AN OPEN LABEL EXTENSION STUDY
    Genovese, M. C.
    Kremer, J.
    Zhong, S.
    Friedman, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 979 - 979
  • [32] Long-Term Efficacy and Safety of Etrasimod for Ulcerative Colitis: Results From the Open-Label Extension of the OASIS Study
    Chiorean, Michael
    Vermeire, Severine
    Panes, Julian
    Peyrin-Biroulet, Laurent
    Zhang, Jinkun
    Sands, Bruce E.
    Lazin, Krisztina
    Cabell, Chris H.
    Naik, Snehal U.
    Klassen, Preston
    Sandborn, William J.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2019, 114 : S445 - S446
  • [33] Long-term Safety and Efficacy of Etrasimod for Ulcerative Colitis: Results from the Open-label Extension of the OASIS Study
    Vermeire, Severine
    Chiorean, Michael
    Panes, Julian
    Peyrin-Biroulet, Laurent
    Zhang, Jinkun
    Sands, Bruce E.
    Lazin, Krisztina
    Klassen, Preston
    Naik, Snehal U.
    Cabell, Christopher H.
    Sandborn, William J.
    JOURNAL OF CROHNS & COLITIS, 2021, 15 (06): : 950 - 959
  • [34] Long-term safety and efficacy of lanreotide autogel in Japanese patients with neuroendocrine tumors: Final results of a phase II open-label extension study
    Ito, Tetsuhide
    Fujimori, Nao
    Honma, Yoshitaka
    Kudo, Atsushi
    Hijioka, Susumu
    Katsushima, Shinji
    Kimura, Yasutoshi
    Fukutomi, Akira
    Hisamatsu, Seiichi
    Nakajima, Akihiro
    Shimatsu, Akira
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2021, 17 (05) : E153 - E161
  • [35] Safety and efficacy of eltrombopag for treatment of chronic immune thrombocytopenia: results of the long-term, open-label EXTEND study
    Saleh, Mansoor N.
    Bussel, James B.
    Cheng, Gregory
    Meyer, Oliver
    Bailey, Christine K.
    Arning, Michael
    Brainsky, Andres
    BLOOD, 2013, 121 (03) : 537 - 545
  • [36] Efficacy and Safety of Canakinumab in Patients with Systemic Juvenile Idiopathic Arthritis: Results from an Open-Label Long-Term Followup Study
    Brunner, Hermine L.
    Ruperto, Nicolino
    Quartier, Pierre
    Constantin, Tamas
    Alexeeva, Ekaterina
    Schneider, Rayfel
    Kone-Paut, Isabelle
    Schikler, Kenneth
    Marzan, Katherine
    Wulffraat, Nico
    Padeh, Shai
    Chasnyk, Vyacheslav
    Wouters, Carine
    Kuemmerle-Deschner, Jasmin B.
    Kallinich, Tilmann
    Lauwerys, Bernard
    Haddad, Elie
    Nasonov, Evgeny L.
    Trachana, Maria
    Vougiouka, Olga
    Leon, Karolynn
    Speziale, Antonio
    Lheritier, Karine
    Vritzali, Eleni
    Lovell, Daniel J.
    Martini, Alberto
    ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [37] LONG-TERM EFFICACY OF LANADELUMAB: INTERIM RESULTS FROM THE HELP OPEN-LABEL EXTENSION STUDY
    Riedl, M.
    Cicardi, M.
    Hao, J.
    Lu, P.
    Li, H.
    Manning, M.
    Bernstein, J.
    Busse, P.
    Tachdjian, R.
    Gower, R.
    Wedner, H.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2019, 123 (05) : S30 - S31
  • [38] Long-term treatment with lumasiran: final results from the phase 2 open-label extension study
    Frishberg, Yaacov
    Groothoff, Jaap W.
    Hulton, Sally-Anne
    Harambat, Jerome
    Hogan, Julien
    Anne-Laure, Sellier-Leclerc
    Hayes, Wesley
    Coenen, Martin
    Willey, Richard
    Gansner, John
    Magen, Daniella
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39
  • [39] Long-term treatment with lumasiran: final results from the phase 2 open-label extension study
    Frishberg, Yaacov
    Groothoff, Jaap W.
    Hulton, Sally-Anne
    Harambat, Jerome
    Hogan, Julien
    Anne-Laure, Sellier-Leclerc
    Hayes, Wesley
    Coenen, Martin
    Willey, Richard
    Gansner, John
    Magen, Daniella
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39 : I2390 - I2392
  • [40] Long-Term Efficacy, Safety, and Pharmacokinetics of Drisapersen in Duchenne Muscular Dystrophy: Results from an Open-Label Extension Study
    Goemans, Nathalie M.
    Tulinius, Mar
    van den Hauwe, Marleen
    Kroksmark, Anna-Karin
    Buyse, Gunnar
    Wilson, Rosamund J.
    van Deutekom, Judith C.
    de Kimpe, Sjef J.
    Lourbakos, Afrodite
    Campion, Giles
    PLOS ONE, 2016, 11 (09):
12345